NASDAQ:NOTV Inotiv - NOTV Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Inotiv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $7.93 -0.19 (-2.34%) (As of 02/6/2023 04:31 PM ET) Add Compare Share Share Today's Range$7.68▼$8.1350-Day Range$3.77▼$8.6452-Week Range$3.64▼$42.63Volume366,628 shsAverage Volume1.01 million shsMarket Capitalization$203.18 millionP/E RatioN/ADividend YieldN/APrice Target$17.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Inotiv MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside121.1% Upside$17.33 Price TargetShort InterestBearish12.69% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$18,476 Sold Last QuarterProj. Earnings Growth157.14%From $0.35 to $0.90 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.36 out of 5 starsMedical Sector206th out of 1,027 stocksCommercial Physical Research Industry4th out of 16 stocks 3.3 Analyst's Opinion Consensus RatingInotiv has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.33, Inotiv has a forecasted upside of 121.1% from its current price of $7.84.Amount of Analyst CoverageInotiv has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted12.69% of the float of Inotiv has been sold short.Short Interest Ratio / Days to CoverInotiv has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inotiv has recently increased by 0.40%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldInotiv does not currently pay a dividend.Dividend GrowthInotiv does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NOTV. Previous Next 2.6 News and Social Media Coverage News SentimentInotiv has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Inotiv this week, compared to 2 articles on an average week.Search InterestOnly 10 people have searched for NOTV on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days.MarketBeat Follows9 people have added Inotiv to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inotiv insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,476.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Inotiv is held by insiders.Percentage Held by Institutions52.04% of the stock of Inotiv is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Inotiv are expected to grow by 157.14% in the coming year, from $0.35 to $0.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inotiv is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inotiv is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInotiv has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inotiv (NASDAQ:NOTV) StockInotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Research Services and Research Products. The Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.Read More Receive NOTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter. Email Address NOTV Stock News HeadlinesFebruary 1, 2023 | finance.yahoo.comInotiv Selected as a Winner of the 2023 Top Workplaces USA AwardJanuary 23, 2023 | finance.yahoo.comInotiv, Inc. Announces Changes to Board of DirectorsFebruary 6, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 16, 2023 | seekingalpha.comInotiv: High Expenses Likely To Impair Long-Term ProfitabilityJanuary 12, 2023 | finance.yahoo.comInotiv, Inc. (NASDAQ:NOTV) Q4 2022 Earnings Call TranscriptJanuary 11, 2023 | benzinga.comWhy Inotiv Shares Are Shooting Higher TodayJanuary 11, 2023 | seekingalpha.comInotiv stock soars ~20% as FQ4 revenue surges 400%; provides fiscal '23 outlookJanuary 10, 2023 | finance.yahoo.comInotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial ResultsFebruary 6, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 10, 2023 | finance.yahoo.comInotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial ResultsJanuary 10, 2023 | benzinga.com$1000 Invested In Inotiv 5 Years Ago Would Be Worth This Much TodayJanuary 9, 2023 | msn.comEarnings Outlook For InotivJanuary 4, 2023 | finance.yahoo.comInotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023December 29, 2022 | benzinga.comHere's How Much $100 Invested In Inotiv 5 Years Ago Would Be Worth TodayDecember 28, 2022 | benzinga.comInotiv Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmDecember 12, 2022 | msn.comInotiv stock slides 25% on weak guidance weighed by supplier's non-human primate chargesDecember 12, 2022 | finance.yahoo.comInotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial ResultsDecember 9, 2022 | msn.com$100 Invested In Inotiv 5 Years Ago Would Be Worth This Much TodayDecember 8, 2022 | finance.yahoo.comInotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service OfferingsNovember 30, 2022 | finance.yahoo.comInotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in ProcessNovember 28, 2022 | finance.yahoo.comInotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022November 22, 2022 | finance.yahoo.comInvestors might be losing patience for Inotiv's (NASDAQ:NOTV) increasing losses, as stock sheds 59% over the past weekNovember 18, 2022 | msn.comAnalyzing Inotiv's Short InterestNovember 17, 2022 | msn.comWhat Does Inotiv's Debt Look Like?November 17, 2022 | msn.comHere's How Much $1000 Invested In Inotiv 5 Years Ago Would Be Worth TodayNovember 1, 2022 | finance.yahoo.comInotiv, Inc. to Participate in November Investor ConferencesOctober 27, 2022 | finance.yahoo.comIs Inotiv (NOTV) Stock Undervalued?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NOTV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter. Email Address NOTV Company Calendar Last Earnings1/10/2023Today2/06/2023Next Earnings (Estimated)2/09/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NOTV CUSIPN/A CIK720154 Webwww.inotivco.com Phone(765) 463-4527Fax765-497-1102Employees2,204Year FoundedN/APrice Target and Rating Average Stock Price Forecast$17.33 High Stock Price Forecast$34.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+118.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($13.86) Trailing P/E RatioN/A Forward P/E Ratio22.66 P/E GrowthN/ANet Income$-337,020,000.00 Net Margins-61.54% Pretax Margin-64.36% Return on Equity-4.36% Return on Assets-2.23% Debt Debt-to-Equity Ratio0.92 Current Ratio1.42 Quick Ratio0.98 Sales & Book Value Annual Sales$547.66 million Price / Sales0.37 Cash Flow$1.10 per share Price / Cash Flow7.23 Book Value$14.06 per share Price / Book0.56Miscellaneous Outstanding Shares25,622,000Free Float24,136,000Market Cap$203.18 million OptionableNot Optionable Beta2.61 Key ExecutivesRobert LeasurePresident, Chief Executive Officer & DirectorJohn Gregory BeattieCOO-Discovery & Development ServicesBeth A. TaylorChief Financial Officer & Senior Vice PresidentMo DastagirChief Technology OfficerAdrian HardyExecutive Vice PresidentKey CompetitorsData Knights AcquisitionNASDAQ:DKDCAAbsciNASDAQ:ABSIScience 37NASDAQ:SNCEOmniAbNASDAQ:OABIMaxCyteNASDAQ:MXCTView All CompetitorsInsiders & InstitutionsSimplex Trading LLCBought 143,800 shares on 2/2/2023Ownership: 0.000%Rice Hall James & Associates LLCSold 11,041 shares on 1/27/2023Ownership: 0.546%Oak Family Advisors LLCBought 12,039 shares on 1/27/2023Ownership: 0.129%Private Advisor Group LLCBought 8,462 shares on 1/18/2023Ownership: 0.351%Next Capital Management LLCBought 20,000 shares on 1/12/2023Ownership: 0.078%View All Insider TransactionsView All Institutional Transactions NOTV Stock - Frequently Asked Questions Should I buy or sell Inotiv stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inotiv in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NOTV shares. View NOTV analyst ratings or view top-rated stocks. What is Inotiv's stock price forecast for 2023? 3 analysts have issued 12-month price targets for Inotiv's shares. Their NOTV share price forecasts range from $8.00 to $34.00. On average, they anticipate the company's share price to reach $17.33 in the next twelve months. This suggests a possible upside of 123.1% from the stock's current price. View analysts price targets for NOTV or view top-rated stocks among Wall Street analysts. How have NOTV shares performed in 2023? Inotiv's stock was trading at $4.94 at the beginning of the year. Since then, NOTV shares have increased by 57.3% and is now trading at $7.77. View the best growth stocks for 2023 here. When is Inotiv's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023. View our NOTV earnings forecast. How were Inotiv's earnings last quarter? Inotiv, Inc. (NASDAQ:NOTV) announced its earnings results on Tuesday, January, 10th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $150.47 million for the quarter. Inotiv had a negative net margin of 61.54% and a negative trailing twelve-month return on equity of 4.36%. What guidance has Inotiv issued on next quarter's earnings? Inotiv updated its FY 2022 earnings guidance on Monday, December, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $547.70 million-$547.70 million, compared to the consensus revenue estimate of $550.98 million. What is Inotiv's stock symbol? Inotiv trades on the NASDAQ under the ticker symbol "NOTV." Who are Inotiv's major shareholders? Inotiv's stock is owned by a number of retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%), Rice Hall James & Associates LLC (0.55%), Private Advisor Group LLC (0.35%), Oak Family Advisors LLC (0.13%), Next Capital Management LLC (0.08%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gregory Cole Davis, James Harkness, John E Sagartz, John E Sagartz, John Gregory Beattie, Michael Garrett, Philip A Downing, R Matthew Neff, Robert Jr Leasure and William D Pitchford. View institutional ownership trends. How do I buy shares of Inotiv? Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Inotiv's stock price today? One share of NOTV stock can currently be purchased for approximately $7.77. How much money does Inotiv make? Inotiv (NASDAQ:NOTV) has a market capitalization of $199.08 million and generates $547.66 million in revenue each year. The company earns $-337,020,000.00 in net income (profit) each year or ($13.86) on an earnings per share basis. How many employees does Inotiv have? The company employs 2,204 workers across the globe. How can I contact Inotiv? Inotiv's mailing address is 2701 KENT AVENUE, WEST LAFAYETTE IN, 47906. The official website for the company is www.inotivco.com. The company can be reached via phone at (765) 463-4527, via email at ir@basinc.com, or via fax at 765-497-1102. This page (NASDAQ:NOTV) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.